November 26, 2019 By Lauren Mendelsohn On November 25, 2019 the United States Food & Drug Administration (FDA) sent out warning letters to 15 different companies for selling CBD products that violate the Food, Drug, and Cosmetic Act (FD&C Act). In addition to sending these new warning letters, the FDA […]
Read More
November 12, 2019 By Lauren Mendelsohn, Esq. On October 31, 2019 the United States Department of Agriculture (USDA) Agricultural Marketing Service (AMS) published an Interim Final Rule for hemp production under the 2018 Farm Bill. We previously discussed the 2018 Farm Bill here. The Interim Final Rule outlines the process […]
Read More
By Andrew Kingsdale, Esq. (with Omar Figueroa, Esq.) September 12, 2019 Introduced by Republican Senator Scott Wilk, California Senate Bill 153 has made it out of the Legislature and is likely to be signed into law soon. This hemp cultivation bill will amend and supplement existing laws governing industrial hemp […]
Read More
May 1, 2019 – On April 30, 2019 the California Department of Food & Agriculture announced that applications to lawfully cultivate hemp pursuant to the state’s industrial hemp law are now available. This follows the Office of Administrative Law (OAL)’s recent adoption of the regulation dealing with industrial hemp registration […]
Read More
By Associate Attorney Lauren Mendelsohn April 8, 2019 Last week, the Commissioner of the United States Food and Drug Administration (FDA), Scott Gottlieb, M.D., issued a press release regarding the FDA’s current standpoint with regards to cannabinoids including CBD. In the press release, the FDA states that interest in products […]
Read More
by Lauren Mendelsohn & Omar Figueroa, December 31, 2018 On December 20, 2018, President Donald Trump signed the Agriculture Improvement Act of 2018 (“Farm Bill”), which decriminalizes hemp and products derived from hemp under federal law. The Farm Bill defines “hemp” as follows: HEMP.—The term ‘hemp’ means the plant […]
Read More
September 28, 2018 – On Thursday, September 27, 2018 the Drug Enforcement Administration (DEA) filed a rule, which was officially published on September 28, 2018, that placed certain FDA-approved medications containing cannabinoids in Schedule V, allowing them to be sold to the public here in the United States. Schedule V […]
Read More
January 22, 2018 – On Saturday, January 20, 2018, the federal government partially shut down due to the failure of Congress to pass a budget. Since the minimal protection that medical cannabis has enjoyed at the federal level exists as a rider to the federal budget, this government shutdown caused […]
Read More
January 4, 2018 – Today, United States Attorney General Jefferson B. Sessions, III rescinded a number of federal memoranda that provided guidance regarding marijuana and medical marijuana enforcement. Included in the memos that were rescinded is the Cole Memo, which laid out eight marijuana enforcement priorities for federal prosecutors in […]
Read More
August 28, 2017 Federal trademarks registered with the United States Patent and Trademark Office (“USPTO”) are valuable business assets that, if possible, should be cultivated and protected. The ® registration symbol can be used in conjunction with a trade or service mark if, and only if, the mark has been […]
Read More